Mechanisms of inverse agonism at G-protein-coupled receptors

Trends in Pharmacological Sciences

Volumn 23, Issue 2, 2002, Pages 89-95

  Strange, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RECEPTOR BLOCKING AGENT;

AGONIST; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STABILITY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPECTRUM;

EID: 0036468505     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)01993-4     Document Type: Review

References (45)

1. An allosteric model for benzodiazepine receptor function
2. Inverse, protean and ligand-selective agonism: Matters of receptor conformation
3. Inverse agonism and the regulation of receptor number
4. Inverse agonism at heptahelical receptors: Concept, experimental approach and therapeutic potential
5. Inverse agonism at G protein coupled receptors: (patho)Physiological relevance and implications for drug discovery
6. Agonist independent regulation of constitutively active G protein coupled receptors
7. 1b adrenergic receptor subtypes
8. 373Lys) and Gαo protein
9. Inverse agonist activity of β-adrenergic agonists
10. Agonist-independent activation of Gz by the 5-hydroxytryptamine1A receptor co-expressed in Spodoptera frugiperda cells
11. Inverse agonism of histamine H2 antagonists accounts for up-regulation of spontaneously active histamine H2 receptors
12. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors
13. Reciprocal binding properties of 5HT2c receptor agonists and antagonists
14. 3 receptors regulates histamine neurones in brain
15. Constitutive activity and structural instability of the wild-type human H2 receptor
16. Nicotinic receptors at the amino acid level
17. A mutation-induced activated state of the β-adrenergic receptor. Extending the ternary complex model
18. The two state model of receptor activation
19. The cubic ternary complex model 1. Model description
20. 2-adrenergic receptor
21. Selective and non selective inverse agonists for constitutively active type 1 PTH receptors: Evidence for altered receptor conformations
22. 2A adrenergic receptor
23. Beta adrenergic receptor kinase: Activity of partial agonists for stimulation of adenylyl cyclase correlates with ability to promote receptor phosphorylation
24. 2 adrenergic receptor
25. Spontaneous association between opioid receptors and GTP binding regulatory proteins in native membranes: Specific regulation by antagonists and sodium ions
26. Drug efficacy at guanine nucleotide binding regulatory protein linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand
27. Mechanisms of agonism and inverse agonism at serotonin 5HT1A receptors
28. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart
29. Two populations of binding sites for antagonists in rat heart
30. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin like growth factor receptor 1. Evidence for a new model of receptor/ligand interactions
31. Interaction of purified bovine brain A1 adenosine receptor with G proteins
32. Dopamine receptors of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists
33. The ternary complex model
34. Guanine nucleotides modulate the affinity of antagonists at adrenergic receptors
35. 3H]spiperone discriminates between the G protein coupled and uncoupled forms
36. s in a ligand dependent manner
37. 3H]quinpirole binding to human D2A and D3 receptors: Effects of ions and guanine nucleotides
38. 3H]domperidone binding and its displacement in rat striatal homogenates
39. Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D2 dopamine receptor
40. 2 dopamine receptors in different brain regions
41. G protein coupled receptors. II. Mechanisms of agonist action
42. Porcine M2 muscarinic acetylcholine receptor effector coupling in CHO cells
43. + exchange
44. 3H]YM-09151-2
45. 2 dopamine receptor that adopts the activated conformation